Biopolym. Cell. 2013; 29(2):85-98.
http://dx.doi.org/10.7124/bc.00080B
Огляди
Скільки потрібно стовбурових клітин? (Проблема банкування пуповинної крові)
1Швед А. Д.
  1. Інститут молекулярної біології і генетики НАН України
    Вул. Академіка Заболотного, 150, Київ, Україна, 03680

Abstract

В огляді розглянуто літературні дані, присвячені питанням банкування пуповинної крові (ПК) в різних країнах і регіонах. Серед існуючих форм банків – приватних, змішаних і публічних – останнім віддають перевагу більшість клініцистів, що мають практику трансплантації стовбурових клітин. Необхідність розвитку банків ПК визнають усі дослідники, однак відзначають, що прогрес цього руху залежить від низки обставин: дефіциту державного фінансування та браку обізнаності населення про можливості клітинної терапії, про доцільність і суспільну значущість запасів ПК у національних банках країни.
Keywords: стовбурові клітини, банкування пуповинної крові
Повний текст: (PDF, російською)

References

[1] Maiers M., Bakker J. N., Bochtler W., Eberhard H. P., Marsh S. G., Muller C., Rist H. G.; Information Technology Working Group (ITWG) of the WMDA. Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products Bone Marrow Transplant 2010 45, N 5 P. 839–842.
[2] Shaw B. E. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation Int. J. Immunogenet 2008 35, N 4–5 P. 367–374.
[3] Petersdorf E. W., Gooley T., Malkki M., Anasetti C., Martin P., Woolfrey A., Smith A., Mickelson E., Hansen J. A. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation Br. J. Haematol 2001 112, N 4 P. 988–994.
[4] Shaw B. E., Gooley T. A., Malkki M., Madrigal J. A., Begovich A. B., Horowitz M. M., Gratwohl A., Ringden O., Marsh S. G., Petersdorf E. W. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation Blood 2007 110, N 13 P. 4560–4566.
[5] Petersdorf E. W., Gooley T., Malkki M., Horowitz M., International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors Tissue Antigens 2007 69, Suppl. 1 P. 25–30.
[6] Eapen M., Rubinstein P., Zhang M. J., Stevens C., Kurtzberg J., Scaradavou A., Loberiza F. R., Champlin R. E., Klein J. P., Horowitz M. M., Wagner J. E. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study Lancet 2007 369, N 9577 P. 1947–1954.
[7] Fleischhauer K., Shaw B. E., Gooley T., Malkki M., Bardy P., Bignon J. D., Dubois V., Horowitz M. M., Madrigal J. A., Morishima Y., Oudshoorn M., Ringden O., Spellman S., Velardi A., Zino E., Petersdorf E. W., International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic cell transplantation: a retrospective study Lancet Oncol 2012 13, N 4 P. 366–374.
[8] Dickinson A. M., Middleton P. G., Rocha V., Gluckman E., Holler E., Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants Br. J. Haematol 2004 127, N 5 P. 479–490.
[9] Waldron J., McCourty A., Lecanu L. Neural stem cell sex dimorphism in aromatase (CYP19) expression: a basis for differential neural fate Stem Cells and Cloning: Advances and Applications 2010 20120:3 P. 175–182.
[10] Waldron J., McCourty A., Lecanu L. Aging differentially affects male and female neural stem cell neurogenic properties Stem Cells and Cloning: Advances and Applications 2010 2010: 3 P. 119–127.
[11] Lavasani M., Robinson A. R., Lu A., Song M., Feduska J. M., Ahani B., Tilstra J. S., Feldman C. H., Robbins P. D., Niedernhofer L. J., Huard J. Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model Nat. Commun 2012 3 P. 608.
[12] Myaskovsky L., Switzer G. E., Dew M. A., Goycoolea J. M., Confer D. L., Abress L. The association of donor center characteristics with attrition from the national marrow donor registry Transplantation 2004 77, N 6 P. 874–880.
[13] Zhong X. Y., Zhang B., Asadollahi R., Low S. H., Holzgreve W. Umbilical cord blood stem cells: what to expect Ann. N. Y. Acad. Sci 2010 1205 P. 17–22.
[14] Gluckman E., Broxmeyer H. A., Auerbach A. D., Friedman H. S., Douglas G. W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P., Cooper S., English D., Kurtzberg J., Bard J., Boyse E. A. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLAidentical sibling N. Engl. J. Med 1989 321, N 17 P. 1174–1178.
[15] Rubinstein P., Taylor P. E., Scaradavou A., Adamson J. W., Migliaccio G., Emanuel D., Berkowitz R. L., Alvarez E., Stevens C. E. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program Blood Cells 1994 20, N 2–3 P. 587–596.
[16] Rubinstein P., Dobrila L., Rosenfield R. E., Adamson J. W., Migliaccio G., Migliaccio A. R., Taylor P. E., Stevens C. E. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution Proc. Natl Acad. Sci. USA 1995 92, N 22 P. 10119–10122.
[17] Rubinstein P. Cord blood banking for clinical transplantation Bone Marrow Transplant 2009 44, N 10 P. 635–642.
[18] Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A. R., Berkowitz R. L., Cabbad M., Dobrila N. L., Taylor P. E., Rosenfield R. E., Stevens C. E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors N. Engl. J. Med 1998 339, N 22 P. 1565–1577.
[19] Fisk N. M., Atun R. Public-private partnership in cord blood banking BMJ 2008 336, N 7645 P. 642–644.
[20] Rosenthal J., Woolfrey A. E., Pawlowska A., Thomas S. H., Appelbaum F., Forman S. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: an opportunity to revisit the controversy regarding cord blood banking for private use Pediatr. Blood Cancer 2011 56, N 7 P. 1009–1012.
[21] Halasa M., Baskiewicz-Masiuk M., Dabkowska E., Machalinski B. An efficient two-step method to purify very small embryonic-like (VSEL) stem cells from umbilical cord blood (UCB) Folia Histochem. Cytobiol 2008 46, N 2 P. 239–243.
[22] Anzalone R., Lo Iacono M., Corrao S., Magno F., Loria T., Cappello F., Zummo G., Farina F., La Rocca G. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity Stem Cells Dev 2010 19, N 4 P. 423–38.
[23] Ballen K. K., Barker J. N., Stewart S. K., Greene M. F., Lane T. A., American Society of Blood and Marrow Transplantation Collection and preservation of cord blood for personal use Biol. Blood Marrow Transplantat 2008 14, N 3 P. 356–363.
[24] Ballen K. Challenges in umbilical cord blood stem cell banking for stem cell reviewers and reports Stem Cell Rev 2010 6, N 1 P. 8–14.
[25] Gratwohl A., Baldomero H., Frauendorfer K., Rocha V., Apperley J., Niederwieser D., Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT), European Group for Blood and Marrow Transplantation EBMT (JACIE) The EMBT activity survey 2006 on haematopoietic stem cells transplantation: focus on the use of cord blood products Bone Marrow Transplant 2008 41, N 8 P. 687–705.
[26] Capone F., Lombardini L., Pupella S., Grazzini G., Costa A. N., Migliaccio G. Cord blood stem cell banking: a snapshot of the Italian situation Transfusion 2011 51, N 9 P. 1985– 1994.
[27] Gluckman E. History of cord blood transplantation Bone Marrow Transplant 2009 44, N 10 P. 621–626.
[28] Fisk N. M., Roberts I. A., Markwald R., Mironov V. Can routine commercial cord blood banking be scientifically and ethically justified? PLoS Med 2005 2, N 2 e44.
[29] Thornley I., Eapen M., Sung L., Lee S. J., Davies S. M., Joffe S. Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians Pediatrics 2009 123, N 3 P. 1011–1017.
[30] Petrini C., Lombardini L., Pupella S., Nanni Costa A., Grazzini G. Collection, storage, and allogeneic use of cord blood: informed consent form used by the Italian biobank network Biopreservation and Biobanking 2011 9, N 3 P. 273–278.
[31] Gluckman E. Milestones in umbilical cord blood transplantation Blood Rev 2011 25, N 6 P. 255–259.
[32] Lauber S., Latta M., Kluter H., Muller-Steinhardt M. The Mannheim cord blood bank: experiences and perspectives for the future Transfus. Med. Hemother 2010 37, N 2 P. 90–97.
[33] Broxmeyer H. E. Umbilical cord transplantation: epilogue Semin. Hematol 2010 47, N 1 P. 97–103.
[34] Querol S., Mufti G. J., Marsh S. G. Pagliuca A., Little A. M., Shaw B. E., Jeffery R., Garcia J., Goldman J. M., Madrigal J. A. Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? Haematologica 2009 94, N 4 P. 536–541.
[35] Howard D. H., Meltzer D., Kollman C., Maiers M., Logan B., Gragert L., Setterholm M., Horowitz M. M. Use of costeffectiveness analysis to determine inventory size for a national cord blood bank Med. Decis. Making 2008 28, N 2 P. 243–253.
[36] Kodera Y. The Japan marrow donor program, the Japan cord blood bank network and the Asia blood and marrow transplant registry Bone Marrow Transplant 2008 42, Suppl. 1 S6.
[37] Takanashi M., Tanaka H., Kohsaki M., Nakajima K., Tadokoro K., Nakabayashi M. A suggested total size for the cord blood banks of Japan Bone Marrow Transplant 2011 46, N 7 P. 1014–1015.
[38] Alkindi S., Dennison D. Umbilical cord blood banking and transplantation: a short review Sultan Qaboos Univ. Med. J 2011 11, N 4 P. 455–461.
[39] Dinc H., Sahin N. H. Pregnant women's knowledge and attitudes about stem cells and cord blood banking Int. Nurs Rev 2009 56, N 2 P. 250–256.
[40] Majhail N. S., Brunstein C. G., Wagner J. E. Double umbilical cord blood transplantation Curr. Opin. Immunol 2006 18, N 5 P. 571–575.
[41] Sideri A., Neokleous N., Brunet De La Grange P., Guerton B., Le Bousse Kerdilles M. C., Uzan G., Peste-Tsilimidos C., Gluckman E. An overview of the progress on double umbilical cord blood transplantation Haematologica 2011 96, N 8 P. 1213–1220.
[42] Frassoni F., Varaldo R., Gualandi F., Bacigalupo A., Sambuceti G., Sacchi N., Podesta M. The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases Best Pract. Res. Clin. Haematol 2010 23, N 2 P. 237–244.
[43] Petropoulou A. D., Rocha V. Risk factors and options to improve engraftment in unrelated cord blood transplantation Stem Cells Int 2011 2011 P. 610514.
[44] Perlow J. H. Patients' knowledge of umbilical cord blood banking J. Reprod. Med 2006 51, N 8 P. 642–648.
[45] Katz G., Mills A., Garcia J., Hooper K., McGuckin C., Platz A., Rebulla P., Salvaterra E., Schmidt A. H., Torrabadella M. Banking cord blood stem cells: attitude and knowledge of pregnant women in five European countries Transfusion 2011 51, N 3 P. 578–586.
[46] American academy of pediatrics section on hematology/oncology, American academy of pediatrics section on allergy/immunology, Lubin B. H., Shearer W. T. Cord blood banking for potential future transplantation Pediatrics 2007 119, N 1 P. 165–170.
[47] Greaves M. Pre-natal origins of childhood leukemia Rev. Clin. Exp. Hematol 2003 7, N 3:233–245.
[48] Tomihara K., Dehari H., Yamaguchi A., Abe M., Miyazaki A., Nakamori K., Hareyama M., Hiratsuka H. Squamous cell carcinoma of the buccal mucosa in a young adult with history of allogeneic bone marrow transplantation for childhood acute leukemia Head Neck 2009 31, N 4:565–568.
[49] Brunstein C. G., Gutman J. A., Weisdorf D. J., Woolfrey A. E., Defor T. E., Gooley T. A., Verneris M. R., Appelbaum F. R., Wagner J. E., Delaney C. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood Blood 2010 116, N 20 P. 4693–4699.
[50] Hu Y. X., Luo Y., Tan Y. M., Shi J. M., Sheng L. X., Fu H. R., Liu L. Z., Xu Y. L., Wu K. N., Xiao H. W., Zhang L. F., Yu X. H., Cai Z., Huang H. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation Stem Cells Dev 2012 21, N 2 P. 177–180.
[51] Bartee E., Chan W. M., Moreb J. S., Cogle C. R., McFadden G. Selective purging of human multiple myeloma cells from autologous stem cell transplant grafts using oncolytic myxoma virus Biol. Blood Marrow Transplant 2012 18, N 10 P. 1540–1551.
[52] Hansmeier N., Chao T. C., Goldman L. R., Witter F. R., Halden R. U. Prioritization of biomarker targets in human umbilical cord blood: identification of proteins in infant blood serving as validated biomarkers in adults Environ. Health Perspect 2012 120, N 5 P. 764–769.
[53] Butler M. G., Menitove J. E. Umbilical cord blood banking: an update J. Assist. Reprod. Genet 2011 28, N 8 P. 669–676.
[54] Shved A. D. On the question of the need to create in Ukraine a national cord blood bank Doctor 2004 N 4 P. 37–40.
[55] Zlatev A., Mihaylova A., Baltadjieva D., Ivanova M., Naumova E. Cord blood stem cell transplantation. Why it is necessary to establish a Bulgarian cord blood bank? Cell Tissue Banking 2008 9, N 4 P. 343–346.
[56] Walters M. C., Quirolo L., Trachtenberg E. T., Edwards S., Hale L., Lee J., Morton-Wiley J., Quirolo K., Robertson S., Saba J., Lubin B. Sibling donor cord bloodtransplantation for thalassemia major: experience of the Sibling Donor Cord Blood Program Ann. N. Y. Acad. Sci 2005 1054 P. 206–213.
[57] Smythe J., Armitage S., McDonald D., Pamphilon D., Guttridge M., Brown J., Green A., Brown C., Warwick R. M., Lankester A., Fehily D., Contreras M., Navarrete C., Watt S. M. Directed sibling cord blood banking for transplantation: the 10-year experience in the National Blood Service in England Stem Cells 2007 25, N 8 P. 2087–2093.
[58] Komar I. D., Samus' N. V., Bachantsova N. M. Storing cord blood in Ukraine: status and prospects Cell Transplantation and Tissue Engineering 2006 1, N 1 P. 84–87.
[59] Garcia J. Allogeneic unrelated cord blood banking worldwide: an update Transfus. Apher. Sci 2010 42, N 3 P. 257–263.
[60] Bart T. Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells Clinicoecon. Outcomes Res 2010 2 P. 141–147.
[61] Christopherson G. T., Nesti L. J. Stem cell applications in military medicine Stem Cell Res. Ther 2011 2, N 5 P. 40.
[62] Huzicka I. Could bone marrow transplantation cure AIDS?: review Med. Hypotheses 1999 52, N 3 P. 247–257.
[63] Hutter G., Zaia J. A. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years Clin. Exp. Immunol 2011 163, N 3 P. 284–295.
[64] Chun T. W., Nickle D. C., Justement J. S., Meyers J. H., Roby G., Hallahan C. W., Kottilil S., Moir S., Mican J. M., Mullins J. I., Ward D. J., Kovacs J. A., Mannon P. J., Fauci A. S. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy J. Infect. Dis 2008 197, N 5 P. 714–720.
[65] Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C. M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R. J., Collman R. G., Doms R. W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 1996 382, N 6593 P. 722–725.
[66] Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 1996 86, N 3 P. 367–377.
[67] Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S. J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, Multicenter AIDS Cohort study, Multicenter hemophilia Cohort study, San Francisco City Cohort, ALIVE Study Science 1996 273, N 5283 P. 1856–1862.
[68] Hutter G., Nowak D., Mossner M., Ganepola S., Mussig A., Allers K., Schneider T., Hofmann J., Kucherer C., Blau O., Blau I. W., Hofmann W. K., Thiel E. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation N. Engl. J. Med 2009 360, N 7 P. 692–698.
[69] Deeks S. G., McCune J. M. Can HIV be cured with stem cell therapy? Nat. Biotechnol 2010 28, N 8 P. 807–810.
[70] Hutter G., Thiel E. Allogeneic transplantation of CCR5deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2 AIDS 2011 25, N 2 P. 273–274.
[71] Holt N., Wang J., Kim K., Friedman G., Wang X., Taupin V., Crooks G. M., Kohn D. B., Gregory P. D., Holmes M. C., Cannon P. M. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo Nat. Biotechnol 2010 28, N 8 P. 839–847.
[72] Brass A. L., Dykxhoorn D. M., Benita Y., Yan N., Engelman A., Xavier R. J., Lieberman J., Elledge S. J. Identification of host proteins required for HIV infection through a functional genomic screen Science 2008 319, N 5865 P. 921–926.
[73] Kukcharenko A. P., Kogut G. I., Shved A. D. The scientific and practical use of umbilical cord blood hematopoietic cells Biopolym. Cell 1995 11, N 2 P. 5–14.